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Abstract 
During telophase, the nuclear envelope (NE) reforms around daughter nuclei to ensure proper 
segregation of nuclear and cytoplasmic contents1-4. NE reformation requires the coating of chromatin 
by membrane derived from the Endoplasmic Reticulum and a subsequent annular fusion step to 
ensure the formed envelope is sealed1,2,4,5. How annular fusion is accomplished is unknown, but it is 
thought to involve the p97 AAA-ATPase complex and bears a topological equivalence to the 
membrane fusion event that occurs during the abscission phase of cytokinesis1,6. We find here that the 
Endosomal Sorting Complex Required for Transport-III (ESCRT-III) machinery localises to sites of 
annular fusion in the forming NE and is necessary for proper post-mitotic nucleo-cytoplasmic 
compartmentalisation. The ESCRT-III component Charged Multivesicular Body Protein (CHMP) 2A 
is directed to the forming NE through binding to CHMP4B and provides an activity essential for NE 
reformation. Localisation also requires the p97 complex member Ubiquitin Fusion and Degradation 1 
(UFD1). Our results describe a novel role for the ESCRT-machinery in cell division and demonstrate 
a conservation of the machineries involved in topologically equivalent mitotic membrane remodeling 
events. 
 
Main Text 
The ESCRT-III complex performs a topologically unique membrane fusion, allowing release of enveloped 
retroviruses during viral budding, intraluminal vesicles during multivesicular body biogenesis, and daughter 
cells during the abscission phase of cytokinesis7-11. We found that as well as localising to the midbody 
during late cytokinesis, endogenous ESCRT-III components CHMP2A and CHMP2B encircled the forming 
daughter nuclei during telophase (Figure 1A, 1B and Extended Data Figure 1A). CHMP2A localisation was 
sensitive to CHMP2A-targeting siRNA (Extended Data Figure 1B) and was not continuous; rather we found 
that CHMP2A adopted a transient punctate localisation around the decondensing nuclei during telophase 
(Extended Data Figure 1C, Supplementary Video 1). By scoring localisation in HeLa cells stably expressing 
mCh-tubulin, (cell cycle of 21.5 ± 1.7 hours, n = 93), we estimate the duration of CHMP2A localisation to 
be 96 ± 8.9 seconds. We found cells expressing GFP-CHMP4B12 also displayed a transient, punctate, juxta-
nuclear localisation during telophase with recruitment of GFP-CHMP4B lasting 225 ± 66 seconds (n = 8, ± 
S.D.) and individual puncta lasting 75 ± 46 seconds (n = 92, ± S.D., Extended Data Figure 1D, 
Supplementary Video 2). Telophase ESCRT-III localisation was observed in other cell lines, including 
human-diploid fibroblasts (Extended Data Figure 1E). Using HeLa cells stably expressing a Yellow 
Fluorescence Protein (YFP)-tagged nuclear envelope marker (Lamin Associated Protein 2β, YFP-LAP2β)13, 
we determined that the juxtanuclear localisation corresponded to the forming nuclear envelope. Here, we 
observed colocalisation with the Lamin B Receptor (LBR)14 (Figure 1C) and demonstrated that CHMP2A 
localisation occurred prior to appreciable formation of a nuclear lamina or nuclear pore complexes 
(Extended Data Figure 1F and 1G). Whilst mitotic chromatin association of ESCRT-III has been previously 
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reported15, its function remains unknown. To investigate the role of ESCRT-components at the NE, we 
employed siRNA to deplete these proteins16. As described previously17, depletion of ESCRT-components 
produced aberrant nuclei and these defects phenocopied those produced by depletion of proteins required for 
NE reformation (Extended Data Figure 1H)18. NE-reformation is thought to be a two-phase process, 
separable into membrane fusion events that create an expanding reticular network with subsequent annular 
fusion of holes within this network to create a sealed barrier1. We next employed correlative light-electron 
microscopy (Extended Data Figure 2A-D) to examine telophase ESCRT-III NE-localisation. We found that 
at the stage of ESCRT-III recruitment, the NE had incompletely formed (Figure 1D). Two populations of 
CHMP2A-positive membranes were found. Firstly, isolated CHMP2A-decorated vesicles were observed in 
the cytoplasm, proximal to the forming NE (5.7 ± 4.2 % of total cellular gold, Extended Data Figure 2Ei). 
Secondly, CHMP2A-decorated double-membrane sheets were observed to coat the chromatin (51 ± 1.7 % of 
total cellular gold was within 100 nm of the NE). On these sheets, CHMP2A localised to discrete regions, 
with intact NE being devoid of label, but with CHMP2A preferentially (Extended Data Figure 2H) 
decorating nucleo-cytoplasmic channels (mean diameter 38.4 ± 12.5 nm (n = 2 ± S.E.M., from 17 
determinations)) between the forming double membranes of the NE (Figure 1D, Extended Data Figure 2D-
2G, Extended Data Figure 3A-D, Supplementary Videos 3 and 4). These channels must be resolved through 
annular fusion and given the observed localisation and topological equivalence with cytokinetic abscission 
(Figure 1E), we speculated that ESCRT-III might be involved in this process. 
 
Requirements for CHMP2A localisation to the telophase NE were revealed through depletion of partner 
ESCRT-proteins, with CHMP4B and CHMP3, as for other ESCRT-dependent membrane remodeling events, 
playing a major role in this recruitment (Figure 2A). We employed siRNA-resistant FLAG-tagged CHMP2A 
expressed at near-endogenous levels to report localisation in the presence of CHMP2A siRNA (Figure 2B 
and 2C). Through introduction of mutations targeting known binding-partners, we found, as for midbody 
recruitment and cytokinetic abscission (Extended Data Figure 4A and 4B), and consistent with the 
previously determined telophase localisation of GFP-CHMP4B (Extended Data Figure 1D), that whilst 
CHMP2AR-FLAG localised to the forming NE, disrupting interaction with CHMP4 proteins by mutation of 
Arg24, Arg27 and Arg31 to Ala (CHMP2AR-FLAG RRR-AAA)16 abolished this localisation. Mutation of 
the N-terminal CHMP2A α0 helix19, or residues involved in the interaction with VPS416 had no effect on NE 
localisation (Figure 2C, Extended Data Figure 4A). These data indicate that CHMP2A is recruited to the 
forming NE through classical assembly of the ESCRT-III complex.  
 
The p97 AAA-ATPase controls both phases of NE reformation; in concert with its adaptor protein p47, it 
regulates membrane delivery and NE expansion whilst through its adaptors Nuclear Protein Like 4 (NPL4) 
and UFD1 it regulates annular fusion6. Through NPL4 and UFD1, the p97 complex extracts ubiquitinated 
Aurora-B, a Chromosomal Passenger Complex (CPC) component, from chromatin to allow chromatin 
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decondensation and membranation20,21. Given our observed ESCRT-III localisation (Figure 1) and known 
interactions of ESCRT-III components with the CPC13, we screened the ESCRT-machinery for interaction 
with the p97 complex by yeast 2-hybrid assay (Extended Data Figure 5A-D). We found that CHMP2A 
bound specifically to UFD1 and confirmed this interaction by direct-binding and co-precipitation assays 
(Figure 3A, 3B and Extended Data Figure 5E-H). We mapped the interaction with CHMP2A to the C-
terminus of UFD1 (Extended Data Figure 5F and 5G) and found that truncation of the C-terminus of 
CHMP2A, or removal of the autoinhibitory helix (α5), prevented interaction with UFD1 (Figure 3A). We 
employed siRNA targeting UFD1 (Extended Data Figure 6A); although its partner protein, p97, was 
required for EGFR degradation22, we found cells depleted for UFD1 degraded EGFR normally (Extended 
Data Figure 6B), allowed release of HIV-1 based lentivirus (Extended Data Figure 6C), and as previously 
reported21, completed cytokinesis normally (Extended Data Figure 6D). However, whilst cells depleted for 
UFD1 recruited CHMP2A to the midbody (Figure 3D), recruitment of CHMP2A to the forming NE was 
impaired (Figure 3C and 3D). 
 
To examine mitotic roles for ESCRT-III in NE reformation, we imaged synchronised cultures of cells stably 
expressing Histone 2B-mCherry (H2B-mCh) and YFP-LAP2β and quantified the time taken to enclose the 
chromatin with YFP-LAP2β positive nuclear envelope. We were surprised to find that cells lacking ESCRT-
III, but not UFD1, enclosed their chromatin faster than control cells (Extended Data Figure 7A-C). To 
explore the integrity of the nascent NE in CHMP2A depleted cells, we followed a protocol similar to that 
recently described23 and imaged synchronised cultures of HeLa cells stably expressing both H2B-mCh and 
GFP-tagged β-Galactosidase (β-Gal) fused to the nuclear localisation signal (NLS) from Simian Virus 40 
(GFP-NLS-βGal)24. GFP-NLS-βGal is released from the nucleus upon NE breakdown at mitotic onset and 
returned upon formation of transport-competent nuclear pores during NE reformation (Extended Data Figure 
8A and 8B). We found that the rate of GFP-NLS-βGal return to the nucleus was slower in ESCRT-III-
depleted cells (Figure 4A-C), despite the cells having enclosed their chromatin with NE membranes faster 
(Extended Data Figure 7A). Whilst nuclei were frequently malformed in ESCRT-III-depleted cells 
(Extended Data Figure 1H17), incorporation of nuclear pore complexes and import machineries were normal 
(Extended Data Figure 8C-8E). However, in CHMP2A-, CHMP3- or UFD1-depleted cells, the post-mitotic 
nucleo-cytoplasmic partitioning of GFP-NLS-βGal was reduced (Figure 4B and 4C, Extended Data Figure 
9A and 9B), indicating that NE integrity was compromised by treatments that prevent ESCRT-III assembly 
at the NE. Results were confirmed with a second reporter (GFP-NLS) (Extended Data Figure 9C) and we 
demonstrated that nuclear retention of this probe was defective in post-mitotic ESCRT-III depleted cells 
(Extended Data Figure 9D and 9E). Using correlative live-cell electron tomography, we found that 
CHMP2A depletion resulted in the persistence of unsealed holes in the post-mitotic NE (Figure 4D and 4E 
and Extended Data Figure 10A and 10B). Paralleling CHMP2 requirements in lentiviral release and 
cytokinetic abscission (Extended Data Figure 6C, and Extended Data Figure 9F), depletion of CHMP2B had 
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minimal effect upon NE integrity (Extended Data Figure 9A and 9B), whilst co-depletion of CHMP2A and 
CHMP2B disrupted NE integrity to a greater extent than CHMP2A depletion alone (Figure 4B). NE 
integrity could be rescued by stable expression of siRNA-resistant CHMP2A-FLAG (CHMP2AR-FLAG), 
but, as with CHMP2A requirements in cytokinesis (Extended Data Figure 4B) and HIV-1 release16, not by 
expression of CHMP2AR-FLAG RRR-AAA (Figure 4F and 4G). We describe a novel localisation and 
function of ESCRT-III in NE remodeling at sites of annular fusion, a process strikingly similar to classical 
ESCRT-III mediated membrane remodeling (Extended Data Figure 10C). Localisation is governed by 
classical ESCRT-III assembly mechanisms and also requires UFD1. An equivalent ESCRT-III-dependent 
membrane remodeling at the NE may allow viruses or megaRNPs to traverse this membrane25-27 and in 
yeast, ESCRT-III has recently been shown to participate in surveillance and extraction of defective 
nucleoporins at the IMN28 indicating additional ESCRT-III activities on this membrane may exist 
throughout the cell cycle. ESCRT-III is thus involved in regulating the quality of the NE and gene expansion 
within the ESCRT-machinery may have resulted from an evolutionary drive to accommodate open mitoses. 
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Figure Legends 
Figure 1 : ESCRT-III localises to the forming nuclear envelope 
A. HeLa cells stained with anti-tubulin, either anti-CHMP2A or anti-CHMP2B and 4',6-diamidino-2-
phenylindole (DAPI). Scale bar is 10 µm, images representative of 3 acquired images in each case. B. 
Quantification of juxta-nuclear CHMP2A localisation during mitosis from A, quantification from 20 cells in 
interphase, prophase, pro-metaphase and metaphase, 23 cells in anaphase, 24 cells in telophase, 36 cells in 
early cytokinesis and 20 cells in late cytokinesis. C. HeLa cells stained with DAPI, anti-CHMP2A or anti-
CHMP2B and either stably expressing YFP-LAP2β, or stained with anti-LBR. Arrows indicate regions of 
colocalisation. Scale bar is 10 µm, images representative of 2 (anti-CHMP2B and YFP-LAP2β, anti-LBR 
and anti-CHMP2A) or 4 (anti-CHMP2A and YFP-LAP2β) acquired images. D. Tomographic slices of HeLa 
cells stained with fluoronanogold anti-CHMP2A. Correlation depicted in Extended Data Figure 2A-2C, 
 6 
arrow indicates nucleocytoplasmic channel, scale bar is 200 nm, image representative of 25 gold-decorated 
nucleocytoplasmic channels and quantified in Extended Data Figure 2H. E. Schematic depicting topological 
equivalence between annular fusion of the NE and ESCRT-dependent membrane fusion events. 
 
Figure 2 : Classical ESCRT-interactions govern CHMP2A telophase-NE localisation 
A. Immunofluorescence and quantification of NE localisation in HeLa cells transfected with the indicated 
siRNA and stained with anti-CHMP2A, anti-tubulin and DAPI (Number of cells scored from 4 independent 
experiments: Control, 58; CHMP4A, 59; CHMP4B, 55; CHMP4C, 53; CHMP3, 64; CHMP1A, 47; 
CHMP1B 52; CHMP2B, 44. Percentage NE localisation given ± S.D. * P = 0.014, ** P = 0.0004 (2-tailed 
Student’s T-test), Scale bar is 10 µm, images representative of 47 cells (Control), 26 cells (CHMP4B 
siRNA) and 42 cells (CHMP3 siRNA). B. Western blotting of lysates from siRNA-depleted HeLa cells 
stably expressing mCherry-tubulin and the indicated CHMP2AR-FLAG with anti-FLAG, anti-CHMP2A or 
anti-GAPDH antisera. C. Immunofluorescence of CHMP2AR-FLAG recruitment to the telophase NE in 
CHMP2A-depleted cells. Scale bar is 10 µm, quantification in Extended Data Figure 4A, images 
representative of 30 cells (Control), 26 cells (L4D/F5D), 30 cells (RRR-AAA) and 26 cells (L216D/L219D).  
 
Figure 3 : UFD1 directs NE-localisation of CHMP2A 
A. β-galactosidase activity of yeast co-transformed with the indicated Gal4 and VP16 fused proteins (n = 3 ± 
S.D.). B. MST experiments displaying interaction of HIS-UFD1 with CHMP2A (Fraction unbound 
displayed, n = 5 ± S.D.) C, D. Immunofluorescence (D) and quantification of NE localisation (C: Control, 35 
cells; UFD1-1, 42 cells; UFD1-2, 25 cells; UFD1-3, 39 cells; average ± S.D. presented from 4 independent 
experiments) in HeLa cells transfected with the indicated siRNA and stained with anti-CHMP2A, anti-
tubulin and DAPI, scale bar is 10 µm, images representative of 23 cells (Control), 34 cells (UFD1-1) 14 cells 
(UFD1-2) and 24 cells (UFD1-3).  
 
Figure 4: ESCRT-III depletion disrupts nuclear envelope integrity 
A. Timelapse analysis of NE-sealing in siRNA transfected HeLa cells stably expressing H2B-mCh and GFP-
NLS-βGal. GFP-signal presented according to pseudocolour scale at the indicated timepoints. Scale bar is 10 
µm, a single image was pseudocoloured for demonstrative purposes. B. Quantification of NE-sealing from 
siRNA treated cells as in A, (Cells were quantified at each time point; Ctrl 140 cells from 7 independent 
experiments; CHMP2A-1, 98 cells from 5 independent experiments, P = 0.047; CHMP2A-2, 80 cells from 4 
independent experiments, P = 0.023; CHMP2A + CHMP2B, 60 cells from 3 independent experiments, P = 
0.006; CHMP3, 34 cells from 3 independent experiments, P = 0.002. All values quoted ± S.E.M.; 2-tailed 
Student’s t-test used to assess significance after 85 minutes). C. Western blotting of cell lysates from B with 
anti-CHMP2A, anti-CHMP2B anti-CHMP3 or anti-GAPDH antisera. D. Z-slices extracted from a 
correlative tomographic reconstruction of the NE at 60 minutes post anaphase onset from the indicated 
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siRNA-transfected mCh-Tub HeLa cells. The numbered circles correspond to discontinuities labeled in the 
3D reconstructions in Extended Data Figure 10A, scale bar is 200 nm, image representative of 6 (control) 
and 12 (CHMP2A-1 siRNA) tomographic reconstructions. E. The percentage of discontinuities smaller than 
65 nm was scored. Discontinuities in this range that were not NPCs as a percentage of total discontinuities 
(including NPCs) for n number of reconstructed tomograms: Control 9.4 ± 3.0, n = 6; CHMP2A-1, 29.9 ± 
4.7, P = 0.01, n = 12; CHMP2A-2, 28.3 ± 2.0, P  = 0.021, n = 2. The increase in the percentage of non-NPC 
discontinuities was assessed by 2-tailed Student’s T-test (average diameter of non-NPC discontinuities was 
38 ± 22 nm (CHMP2A-1) and 58 ± 19 nm (CHMP2A-2)). F. Western blotting of lysates from siRNA-treated 
HeLa cells stably expressing H2B-mCh, GFP-NLS-βGal and siRNA-resistant CHMP2AR-FLAG with anti-
CHMP2A, anti-FLAG or anti-GAPDH antisera. G. Quantification of NE-sealing from cells treated with 
siRNA as in F and imaged from 4 independent experiments, (Mean nucleo-cytoplasmic ratio given 85 
minutes post anaphase onset ± S.D, 2-tailed Student’s T-test was used to assess significance across 4 
independent experiments (*); Ctrl, 8.9 ± 3.1, n = 174 ; CHMP2A siRNA 5.4 ± 2.6, n = 171, P = 0.0006; 
CHMP2A siRNA + CHMP2AR-FLAG 8.4 ± 3.3, n = 132, not-significant; CHMP2A siRNA + CHMP2AR-
FLAG RRR-AAA  5.4 ± 2.2, n = 196, P = 0.0001).  
 
 
  
 8 
References 
1. Burke, B. The nuclear envelope: filling in gaps. Nat. Cell Biol. 3, E273–4 (2001). 
2. Anderson, D. J. & Hetzer, M. W. Shaping the endoplasmic reticulum into the nuclear envelope. J. 
Cell. Sci. 121, 137–142 (2008). 
3. Schooley, A., Vollmer, B. & Antonin, W. Building a nuclear envelope at the end of mitosis: 
coordinating membrane reorganization, nuclear pore complex assembly, and chromatin de-
condensation. Chromosoma 121, 539–554 (2012). 
4. Burke, B. & Ellenberg, J. Remodelling the walls of the nucleus. Nat. Rev. Mol. Cell Biol. 3, 487–497 
(2002). 
5. Lu, L., Ladinsky, M. S. & Kirchhausen, T. Formation of the postmitotic nuclear envelope from 
extended ER cisternae precedes nuclear pore assembly. J. Cell Biol. 194, 425–440 (2011). 
6. Hetzer, M. et al. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. 
Nat. Cell Biol. 3, 1086–1091 (2001). 
7. McCullough, J., Colf, L. A. & Sundquist, W. I. Membrane Fission Reactions of the Mammalian 
ESCRT Pathway. Annu. Rev. Biochem. (2013). doi:10.1146/annurev-biochem-072909-101058 
8. Carlton, J. G., Agromayor, M. & Martin-Serrano, J. Differential requirements for Alix and ESCRT-III 
in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. U.S.A. 105, 10541–10546 (2008). 
9. Carlton, J. G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding: a role for the 
ESCRT machinery. Science 316, 1908–1912 (2007). 
10. Elia, N., Sougrat, R., Spurlin, T. A., Hurley, J. H. & Lippincott-Schwartz, J. Dynamics of endosomal 
sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in 
abscission. Proc. Natl. Acad. Sci. U.S.A. 108, 4846–4851 (2011). 
11. Morita, E. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and 
function in cytokinesis. EMBO J. 26, 4215–4227 (2007). 
12. Jouvenet, N., Zhadina, M., Bieniasz, P. D. & Simon, S. M. Dynamics of ESCRT protein recruitment 
during retroviral assembly. Nat. Cell Biol. 13, 394–401 (2011). 
13. Carlton, J. G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J. ESCRT-III governs the 
Aurora B-mediated abscission checkpoint through CHMP4C. Science 336, 220–225 (2012). 
14. Clever, M., Funakoshi, T., Mimura, Y., Takagi, M. & Imamoto, N. The nucleoporin ELYS/Mel28 
regulates nuclear envelope subdomain formation in HeLa cells. Nucleus 3, 187–199 (2012). 
15. Stauffer, D. R., Howard, T. L., Nyun, T. & Hollenberg, S. M. CHMP1 is a novel nuclear matrix 
protein affecting chromatin structure and cell-cycle progression. J. Cell. Sci. 114, 2383–2393 (2001). 
16. Morita, E. et al. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 9, 235–242 
(2011). 
17. Morita, E. et al. Human ESCRT-III and VPS4 proteins are required for centrosome and spindle 
maintenance. Proc. Natl. Acad. Sci. U.S.A. 107, 12889–12894 (2010). 
18. Asencio, C. et al. Coordination of kinase and phosphatase activities by Lem4 enables nuclear 
envelope reassembly during mitosis. Cell 150, 122–135 (2012). 
19. Buchkovich, N. J., Henne, W. M., Tang, S. & Emr, S. D. Essential N-terminal insertion motif anchors 
the ESCRT-III filament during MVB vesicle formation. Dev. Cell 27, 201–214 (2013). 
20. Ramadan, K. et al. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B 
from chromatin. Nature 450, 1258–1262 (2007). 
21. Dobrynin, G. et al. Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in 
HeLa cells. J. Cell. Sci. 124, 1571–1580 (2011). 
22. Ritz, D. et al. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 
and impaired by VCP disease mutations. Nat. Cell Biol. 13, 1116–1123 (2011). 
23. Anderson, D. J. & Hetzer, M. W. Reshaping of the endoplasmic reticulum limits the rate for nuclear 
envelope formation. J. Cell Biol. 182, 911–924 (2008). 
24. Sorg, G. & Stamminger, T. Mapping of nuclear localization signals by simultaneous fusion to green 
fluorescent protein and to beta-galactosidase. BioTechniques 26, 858–862 (1999). 
25. Lee, C.-P. et al. The ESCRT machinery is recruited by the viral BFRF1 protein to the nucleus-
associated membrane for the maturation of Epstein-Barr Virus. PLoS Pathog. 8, e1002904 (2012). 
26. Pawliczek, T. & Crump, C. M. Herpes simplex virus type 1 production requires a functional ESCRT-
III complex but is independent of TSG101 and ALIX expression. J. Virol. 83, 11254–11264 (2009). 
 9 
27. Speese, S. D. et al. Nuclear envelope budding enables large ribonucleoprotein particle export during 
synaptic Wnt signaling. Cell 149, 832–846 (2012). 
28. Webster, B. M., Colombi, P., Jäger, J. & Lusk, C. P. Surveillance of Nuclear Pore Complex Assembly 
by ESCRT-III/Vps4. Cell 159, 388–401 (2014). 
 
  
 10 
 
Online Supplementary Information 
 
Online Methods 
Cell Culture  
HeLa and 293T cells were kind gifts from Prof Juan Martin-Serrano (KCL) and were cultured in DMEM 
containing 10% FBS, Penicillin (100U/ml) and Streptomycin (0.1 mg/ml). GP2-293 cells were obtained 
from Clontech and were cultured similarly. BJ fibroblasts were obtained from the ATCC and cultured in 4:1 
DMEM : 199 Media, supplemented with 15% FCS, Penicillin (100U/ml) and Streptomycin (0.1 mg/ml). 
Stable cells lines were generated by transduction using MLV-based retroviruses as described previously9, 
and selected using Puromycin (200 ng/ml), G418 (500 µg/ml) or hygromycin (200 µg/ml) as necessary. 
Cells were sorted to monoclonality by limiting dilution or FACS. HeLa cells stably expressing mCh-
Tubulin29 or GFP-CHMP4B12 have been described previously and were kind gifts from Prof Juan Martin-
Serrano (KCL). MycoSensor (Agilent) was used to screen for contamination. 
 
Plasmids 
Plasmids encoding TSG101, EAP20, EAP30, EAP45, CHMP1A, CHMP1B, CHMP2A, CHMP2B, CHMP3, 
CHMP4A, CHMP4B, CHMP4C, CHMP5, VPS4A, LIP5, UBPY, CEP55, TAL, LAP2β and ALG2 were 
kind gifts from Prof. Juan Martin-Serrano (King’s College London) and have been described 
previously8,9,13,30. Coding sequences for p97, p47, NPL4, UFD1, CHMP7, VPS4B and SPARTIN were 
amplified from IMAGE clones (6502535, 3635947, 5017718, 3507963, 5551762, 6042862, 5313378) 
respectively and were cloned into mammalian expression (pCR3.1-YFP) and yeast 2-hybrid plasmids 
(pHB18 and pGBKT7). A plasmid encoding HD-PTP was a kind gift from Prof Phillip Woodman 
(University of Manchester) and was cloned similarly. siRNA resistant CHMP2A constructs were created by 
introducing Q132Q, A133A, E134E, I135I, and D137D silent mutations in the CHMP2A coding sequence 
by PCR. 5’ EcoRI and 3’ NotI sites were added to facilitate cloning. Additional CHMP2A truncations, 
mutations and deletions were created by standard PCR procedures. UFD1 and its deletions were cloned with 
5’ and 3’ NotI sites into relevant expression vectors. CHMP2A constructs were subcloned into pGBKT7 and 
UFD1 constructs were cloned into pHB18 for yeast 2-hybrid analysis. For recombinant protein expression, 
CHMP2A was cloned into pGEX-EcoRI-NotIXhoI and UFD1 constructs were cloned into pET28a (kind 
gifts from Prof Juan Martin-Serrano). A lentiviral expression vector (pLVXP) was a kind gift from Dr Mark 
Dodding (KCL) and modified to express a GFP-EcoRI-NotI-XhoI polylinker by replacing its SnaBI/XbaI 
fragment with a GFP-EcoRI-XhoI-NotI-STOP-XbaI fragment, obtained by PCR from pCR3.1-GFP-EcoRI-
XhoI-NotI (a kind gift from Prof Juan Martin-Serrano, KCL). SnaBI/XhoI fragments of pHM840 (encoding 
GFP-NLS-βGAL and obtained from Thomas Stamminger (Universitätsklinikum Erlangen) via Addgene) 
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were cloned into the SnaBI/XhoI sites of pLVXP-GFP-ENX to produce pLVXP-GFP-NLS-βGAL. pLVXP-
GFP-NLS was obtained by amplifying GFP using primers to incorporate a C-terminal SV40 NLS.  
 
A SnaBI/NotI fragment from pH2B-mCherry-IRES-Neo3 (a kind gift from Dr Ulrike Eggert (King’s 
College London)) was subcloned into SnaBI/Not sites of pLHCX-MCS (a modified version of pLHCX 
containing a HindIII/MluI/SalI/XhoI/NotI/HpaI/BamHI/NsiI/ClaI MCS, a kind gift from Prof T. Ng, King’s 
College London) to create pLHCX-H2B-mCh. LAP2β residues 244-454 were amplified with in-frame NotI 
sites and cloned into the NotI site of pMSCVneo-YFP-EXN to create pMSCVneo-YFP-LAP2β. siRNA-
resistant CHMP2A constructs were cloned with C-terminal FLAG extensions into EcoRI and NotI sites of 
pCR3.1-EXN and subcloned into pNG72-ENX (kind gifts from Prof Juan Martin-Serrano).  
 
For retroviral transduction, above constructs within pMSCVneoYFP-EXN, pNG72  pLHCX-MCS  retroviral 
packaging vectors were transfected with pVSVG into 293GP2 cells (all from Clontech). Supernatants were 
harvested, clarified by centrifugation (200 x g, 5 minutes), filtered (0.45 µm) and used to infect target cells 
in the presence of 8µg/ml polybrene (Millipore) at MOI < 1. For lentiviral transduction, 293T cells were 
transfected with pCMV8.91, pVSVG and either pLVXP-GFP-NLS-βGAL, pLVXP-GFP-NLS-PK or 
pLVXP-GFP-NLS. Supernatants were harvested, clarified by centrifugation (200 x g, 5 minutes), filtered 
(0.45 µm) and used to infect target cells in the presence of 8µg/ml polybrene (Millipore) at MOI < 1. In both 
cases, antibiotic selection was applied after 48 hours.  
 
Antibodies 
Antibodies against HSP90 (H114) were from Santa Cruz Biotechnology, TSG101 (T5701) was from Sigma, 
GAPDH (MAB374) was from Millipore, Tubulin (DM1A) was from Sigma, CHMP2A (104771-AP) was 
from Proteintech, CHMP2B (ab33174) was from Abcam, CHMP4B (sc82556) was from Santa Cruz, 
CHMP3 (sc67228) was from Santa Cruz, UFD1 (106151-AP) was from Proteintech, anti-p24 Gag (183-
H12-5C) was from the NIH AIDS Research and Reference Reagent Program, EGFR (2232) was from Cell 
Signaling Technology, GFP (7.1/13.1) was from Roche, LBR (SAB10400151) was from Sigma, Lamin A/C 
(MAB3538) was from Millipore, mAb414 was from Covance, DYKDDDDK-Tag (FLAG) was from Cell 
Signaling Technology. Alexa conjugated secondary antibodies were from Invitrogen and HRP-conjugated 
secondary antibodies were from Millipore. 
 
SDS-PAGE and western blotting 
Cell lysates were denatured in Laemmli buffer and resolved using SDS-PAGE gels. Resolved proteins were 
transferred onto nitrocellulose by western blotting and were probed with the indicated antisera in 5% milk. 
HRP-conjugated secondary antibodies were incubated with ECL Prime enhanced chemiluminescent 
substrate (GE Healthcare) and visualized by exposure to autoradiography film.  
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Transient transfection of cDNA 
HeLa cells were transfected using Lipofectamine-2000 (Life Technologies) according to the manufacturers 
instructions. 293GP2 and 293T cells were transfected using linear 25-kDa polyethylenimine (PEI, 
Polysciences, Inc.) 
 
siRNA transfections 
Cells were seeded at a density of 1E5 cells/ml (HeLa, BJ) or 2.6E5 cells/ml (293T) and were transfected 
with siRNA at 100nM, 2 hours after plating using Dharmafect-1 (Dharmacon). To minimize toxicity 
associated with CHMP2A and UFD1 depletion, single transfections were performed for 72 hours. The 
following targeting sequences that have already been demonstrated to achieve potent and specific 
suppression of the targeted CHMP were employed: Control – Dharmacon Non-targeting control D-001810-
01. CHMP2A-1 : aggcagagaucauggauaudTdT16, CHMP2A-2 : AAGAUGAAGAGGAGAGUGAdTdT17, 
CHMP2B : UCGAGCAGCUUUAGAGAAAdTdT17, CHMP3 ggaagaagcagaaauggaadTdT17, CHMP4A  Q-
SI0426884513, CHMP4B Q-SI0032519913, CHMP4C Q-SI0427967413, CHMP1A 
CCAAGAAGGCGGAGAAGGAdTdT17, CHMP1B UGGACAAAUUCGAGCACCAdTdT17, UFD1-1 
GAGGCAGAUUCGUCGCUUUdTdT, UFD1-2 MQ-017918-03-0002, UFD1-3 
GUGGCCACCUACUCCAAAUdTdT31, LEM4  GAGAAGACGCUGAGAAAUUdTdT18. UFD1-2 was 
excluded from much of the analysis due to toxicity and morphological changes specific to this oligo. 
 
Yeast Two-Hybrid assays 
Yeast Y190 cells were co-transformed with plasmids encoding the indicated proteins fused to the VP16 
activation domain (pHB18) or the Gal4 DNA-binding domain (pGBKT7). Co-transformants were selected 
on SD-Leu-Trp agar for 3 days at 30 oC, harvested, and LacZ activity was measured using a liquid β-
galactosidase assay employing chlorophenolred-ß-D-galactopyranoside (Roche) as a substrate. Average β-
galactosidase activities presented. 
 
Lentiviral release 
293T cells were transfected with siRNA as described above, except that the second transfection contained 
additionally either 300 ng of HIV-1 pCMVd8.91 (a kind gift from Prof T. Ng, King’s College London), 
100ng of pLenti-SEW (a packaging vector encoding GFP, a kind gift from Prof A. Ridley, King’s College 
London) and 100 ng pVSVG. After 48 hours, virions were harvested from 293T supernatants by filtration 
(0.45 µm) and centrifugation through 20% sucrose (14000 rpm, 120 minutes), lysed, resolved by SDS-
PAGE and examined by western blotting. Additionally, HeLa cells were infected with 50 µl of viral 
supernatant and GFP-expression in these cells was measured by western blotting. Virion Release was 
calculated by quantifying GagVirion/GagCellular as determined densitometry using ImageJ. 
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Co-Precipitation Assays 
293T cells were co-transfected equal quantities of the indicated pCAGGS-GST construct and the relevant 
pCR3.1-YFP construct for 48 hours. Cells were harvested and lysed in 1 ml of 50 mM Tris·HCl, pH 7.4, 150 
mM NaCl, 5 mM EDTA, 5% glycerol, 1% Triton X-100, a protease inhibitor mixture (complete mini-
EDTA-free, Roche). Clarified lysates were incubated with glutathione-Sepharose beads (Amersham 
Biosciences) for 3 h at 4 °C and washed three times with wash buffer (50 mM Tris·HCl, pH 7.4, 150 mM 
NaCl, 5 mM EDTA, 5% glycerol, 0.1% Triton X-100). Bead-bound proteins were recovered in Laemmli 
sample buffer, resolved by SDS-PAGE and examined by western blotting. 
 
Production of recombinant proteins 
BL21* DE3 E. coli expressing plasmids encoding GST-tagged or HIS-tagged proteins were collected in 
bacterial lysis buffer (20mM Hepes (pH 7.4), 500 mM NaCl, supplemented with complete mini, EDTA-free 
protease inhibitor (Roche) and 1 mM PMSF; buffers for HIS-tagged protein purification were supplemented 
with 20mM Imidazole. Cells were lysed by addition of lysosyme (1 mg/ml, 15 minutes), Triton X100 
(0.25%, 15 minutes) and were snap frozen in liquid nitrogen. Cells were thawed on ice, clarified through 
addition of DNAse1 (20 µg/ml) and soluble proteins were collected by centrifugation at 28000 x g for 30 
minutes. Proteins were immobilised on Glutathione Sepharose 4β or Ni-NTA-sepharose resin, washed in 
wash buffer (20mM Hepes, pH7.4, 150mM NaCl), containing 20mM Imidazole if required. Proteins were 
eluted from Glutathione Sepharose 4β resin in wash-buffer supplemented with 10mM reduced Glutathione 
(pH 8), or were eluted from Ni-NTA sepharose with a step gradient of imidazole. CHMP2A was cleaved 
from the GST using AcTEV protease (Life Technologies). Protein concentrations were measured using the 
Qubit assay system (Life Technlogies).  
 
Microscale thermophoresis (MST) 
Measurements were preformed using a Monolith NT.115 instrument (Nanotemper). Briefly, recombinant 
CHMP2A was labeled with Alexa-647 using an NHS Amine-reactive labeling kit (Nanotemper), labeling 
was verified by infrared imaging (Licor). 360nM Alexa-647 CHMP2A was combined with serial dilutions of 
GST, HIS-UFD1 or HIS-UFD1 1-257 (maximally 52.8 µM). Interactions were performed in 150 mM NaCl, 
20 mM Hepes, 0.04% Tween-20 pH 7.4. Temperature jump and thermophoresis experiments were 
conducted using 100% LED illumination and 40% IR laser power and were analysed using Nanotemper’s 
analysis suite. Binding curves could only be generated for the CHMP2A : UFD1 interaction, affinities were 
calculated by the software and averaged.   
 
Fixed cell imaging 
Cells were imaged using Nikon Eclipse microscopes teamed with widefield (Ti-E) and confocal (A1R or 
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Spinning Disc) imaging systems. Widefield image stacks were iteratively deconvolved using Autoquant. 
Images were processed in NIS Elements and exported to Photoshop for assembly. HeLa cells were fixed in 
MeOH (for CHMP2A-staining) or 4% PFA and subject to processing for immunofluorescence as described 
previously9. For multinucleation and midbody arrest assays, at least 300 cells per experiment were 
quantified. For telophase NE localisation, at between 10 and 20 telophase cells per experiment were scored. 
For fixed cell microscopical analysis, we scanned multiple coverslips and experiments before acquiring two 
to three representative images for presentation in figures.   
 
Live cell imaging 
HeLa cells stably expressing the indicated proteins were plated in Stickyslides (Ibidi) adhered to a glass 
number 1 coverslip and transfected with the indicated siRNA. Cells were synchronised using a double 
thymidine block and 48 hours after siRNA transfection (10.5 hours after release from the second thymidine 
block), cells were transferred to a Nikon inverted spinning disc confocal microscope with attached 
environmental chamber and imaged live for 4 hours using a 20x dry objective and a 1.5 x magnification lens. 
For mitotic rim formation, 3 co-ordinates per condition were selected and frames were acquired every 1 min, 
rim formation was scored through manual analysis of individual frames. For nuclear accumulation of GFP-
NLS and GFP-NLS-ßGal, frames were acquired every 1 min. The ratio of background-corrected, area-
normalised, GFP-positive pixel intensities within the cytoplasm and mCh-H2B demarcated nuclei at the 
indicated intervals were obtained using NIS-elements. We excluded 2/98 cells from CHMP2A-1 analysis, 
2/60 cells from UFD1-1 analysis and 2/60 cells from UFD1-3 analysis as these gave anomalous N/C ratios > 
10 x S.D. from the average. For imaging of GFP-CHMP4B recruitment to the telophase NE, cells were 
imaged using a 100x oil-immersion objective and confocal slices were acquired every 30 seconds using a 
spinning disc confocal microscope. For analysis of nuclear retention, siRNA-treated HeLa cells stably 
expressing GFP-NLS and mCh-H2B were imaged live using a Nikon A1R confocal microscope. Between 1 
and 2 hours post anaphase onset, cells were subject to photo-ablation of cytosolic GFP-NLS signal by point 
bleaching and the recovery of cytoplasmic fluorescence from the nuclear pool was quantified for 10 minutes 
post-bleach. 
 
Correlative Light Electron Microscopy 
500,000 HeLa cells were seeded in a 3.5cm Mattek gridded dish (P35G-2-14-C-GRID). The following 
morning, cells were fixed in phosphate buffer containing 1% PFA for 3 minutes. Cells were permeabilised 
with 0.1% saponin in PHEM (60mM PIPES, 25mM HEPES, 10mM EGTA, 2mM MgCl2, pH6.9) and 
processed for immunofluorescence using anti-CHMP2A primary and goat anti-rabbit Alexa594-conjugated 
fluoronanogold (Nanoprobes) and DAPI. Cells were subjected to a subsequent 10-minute 3% PFA fixation 
and quenching prior to imaging on a Leica SP5 or SP8 confocal microscope.   
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After fluorescent imaging, cells were postfixed in glutaraldehyde, subjected to silver enhancement (Aurion 
RGENT SE-EM), stained with OsO4 and uranyl acetate, dehydrated through ethanol and embedded in Epon. 
Blocks were trimmed to the region identified by confocal imaging and 300 nm serial sections were cut using 
a diamond knife32. For retracing of the cells of interest sections were imaged on a FEI Tecnai12 and 
subsequently double tilt series of regions of interest were acquired on a FEI Tecnai20. Tilt series were 
reconstructed using iMOD and selected frames and movies were extracted using ImageJ. 
 
For quantification of holes remaining in the NE after CHMP2A depletion, tomograms were acquired by 
CLEM as described above. Discontinuities in the NE were scored as being NPC or non-NPC on the basis of 
cross sectional morphology. Internal diameters of these discontinuities were measured from reconstructed 
tomograms using FIJI. Discontinuities were segregated by size and whether they were identifiable as NPCs 
or not. A threshold was set at 65 nm (> 2 S.D. smaller than the measured control NPC diameter) and the 
percentage of discontinuities smaller than this was displayed. At least 50 discontinuities were analysed per 
treatment across multiple cells from the indicated number of tomograms. 
 
Statistical analysis 
Variance wan analysed using an F-test and type-relevant 2-tailed Student’s T-tests were used to assess 
significance between test samples and controls.  
 
ImageStream Analysis 
siRNA-treated HeLa cells in 6-well dishes were detached, fixed in 4% PFA, permeabilised with 0.1% Tx100 
and stained in suspension with mAb414, Alexa594 conjugated secondary antibodies and DAPI (at 0.1 µg/ml). 
In-focus, single-cellular populations were acquired and a mask was applied to the DAPI channel and 
duplicated then dilated by 3 pixels to encompass the mAb414 signal surrounding the nuclei. The difference 
in mAb414 signal captured by these masks was given as the nuclear envelope mAb414 and presented as a 
histogram. Representative images of average mAb414 intensity were extracted for presentation.  
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Extended Data Figure Legends 
Extended Data Figure 1 : Localisation of ESCRT components during the cell cycle 
A, B. Immunofluorescence analysis of HeLa cells stained with anti-tubulin, anti-CHMP2A or -CHMP2B 
and DAPI (A). Images in A representative of 2 acquired images per field of view. Cells in B were treated 
with Control or CHMP2A-targeting siRNA, images representative of 4 acquired images (control) or 2 
acquired images (CHMP2A siRNA). C. Deconvolved projections of HeLa cells stained with anti-CHMP2A 
and DAPI, corresponds to stills from Supplemental Video 1, images representative of 2 deconvolved image 
series. D. HeLa cells stably expressing GFP-CHMP4B were imaged live during the anaphase to telophase 
transition. Telophase frames at 30 second intervals are presented, corresponding to stills from Supplemental 
Video 2, images representative of 4 acquisitions. E. Immunofluorescence analysis of human diploid 
fibroblasts stained with anti-CHMP2A, anti-tubulin and DAPI, images representative of 3 acquired cells per 
cell cycle phase. F, G. Immunofluorescence analysis of HeLa cells stained with anti-CHMP2A, DAPI and 
either, anti-mAb414 (F) or anti-LaminA/C (G), images representative of 5 acquired cells. Arrowheads 
indicate regions of formed nuclear pores or lamina as indicated. H. Quantification of abnormal nuclei (the 
presence of multiple lobes, micronuclei, lamina ingression or invagination) in HeLa cells transfected with 
the indicated siRNA and stained with anti-LaminA/C (1300 cells over 5 experiments quantified per 
treatment ± S.D.). Images representative of 3 (control, CHMP2A siRNA) or 2 (LEM4 siRNA) acquired 
fields of view and resolved cell lysates were examined by western blotting with anti-CHMP2A, anti-
CHMP2B or anti-GAPDH antisera as indicated. In all cases, scale bar is 10 µm. 
 
Extended Data Figure 2 : Correlative light and electron microscopy of endogenous CHMP2A 
localisation in telophase NE 
A-C. Phase contrast (A), correlative immunofluorescence (B, scale bar is 10 µm) and transmission electron 
microscopy of HeLa cells stained with anti-CHMP2A, detected by Alexa594-fluoronanogold and DAPI. 
Boxed region in A is shown in B, boxed region in B is shown in C, in all cases, images representative of 3 
cells prepared for CLEM. D. 3D rendering of tomographic reconstruction of forming NE from boxed region 
in C and Figure 1D, a single example of a nucleocytoplasmic channel was selected for 3D rendering. E-G. 
Z-slices extracted from tomographic reconstructions of forming NE depicting CHMP2A-localisation to 
isolated vesicles (Ei) and nucleo-cytoplasmic channels (arrows in Eii, F, G) at the indicated Z-heights, scale 
bar is 200 nm. Localisation of CHMP2A to nucleocytoplasmic channels was observed in 3 independent 
cells, data from a second cell are presented in Extended Data Figure 3. Note CHMP2A localisation to 
nucleocytoplasmic channels is distinct from nuclear pores (asterix in Extended Data Figure 2F). H. 
Quantification of CHMP2A labeling from 2 independently prepared cells, channels were defined as 
discontinuities up to 80 nm, and gaps were defined as discontinuities over 80 nm. Distances of the gold-
particles from channels or gaps were measured on the tomograms in 3-dimensions and plotted as a 
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histogram. The majority (74.4%) of gold label was found within 150 nm of nucleo-cytoplasmic channels and 
the majority (70.6 %) of the gold label was found more than 150 nm from the larger gaps in the NE. 
 
Extended Data Figure 3: Correlative light and electron microscopy of endogenous CHMP2A 
localisation in telophase NE 
A-C. Phase contrast (A), correlative immunofluorescence (B) and transmission electron microscopy (C) of a 
second HeLa cell stained with anti-CHMP2A, detected by Alexa594-fluoronanogold and DAPI. Boxed region 
in A is shown in B, boxed region in B is shown in C. D. Z-slices extracted from tomographic reconstruction 
of forming NE from boxed region in C depicting CHMP2A-localisation to nucleo-cytoplasmic channels at 
the indicated Z-heights. Arrow indicates nucleocytoplasmic channel, scale bar is 200 nm, images in all cases 
representative of 3 cells processed for CLEM, quantification of gold localisation given in Extended Data 
Figure 2H. 
 
Extended Data Figure 4 : Mitotic defects in cells reliant on mutated forms of CHMP2A 
A. Quantification of CHMP2A recruitment to the telophase NE or the midbody from Figure 2C (n = 3 ± 
S.D., 10 cells (midbody or telophase) scored per experiment). B. Quantification of cytokinetic failure from 
cells treated with the indicated siRNA (300 cells were quantified per experiment, from 3 independent 
experiments ± S.D.).  
 
Extended Data Figure 5 : Screening for ESCRT : p97 complex interactions 
A-D. β-galactosidase activity of yeast co-transformed with the indicated Gal4 (ESCRT) and VP16 fused 
proteins (n = 2). E. Resolved cell lysates and glutathione-bound fractions from 293T cells transfected with 
the indicated fusion proteins were examined by western blotting with anti-GFP (n = 3). F. β-galactosidase 
activity of yeast co-transformed with the indicated Gal4 and VP16 fused proteins (n = 3 ± S.D.). G. MST 
experiments detailing binding of CHMP2A to GST (n = 4), HIS-UFD1 (n = 5) or HIS-UFD1 1-257 (n = 4, ± 
S.D.). As no reduction in thermophoresis signal was observed for GST or His-UFD1 1-257 across the 
concentration range, we present here the average thermophoresis signal change at equivalent protein 
concentrations for these three proteins, normalized to zero at the concentration in capillary 1. H. 
CHMP2A647, HIS-UFD1 and HIS-UFD1 1-257 were examined by IR imaging or coomassie staining.  
 
Extended Data Figure 6: UFD1 depletion does not effect ESCRT-dependent receptor degradation, 
lentivirus release or cytokinetic abscission 
A. Resolved cell lysates of HeLa cells transfected with the indicated siRNA were examined by western 
blotting with anti-UFD1 or anti-HSP90 antisera. B. Resolved lysates of human diploid fibroblasts 
transfected with the indicted siRNA and treated for the indicated times with epidermal growth factor (20 
ng/ml) were examined by western blotting with anti-EGFR, anti-UFD1 and anti-GAPDH antisera. EGFR 
 18 
degradation was quantified by densitometry (n = 3, ± S.D.). C. Resolved cell lysates from 293T cells 
transfected with the indicated HIV-1 based lentiviral plasmids, a virally packaged GFP-plasmid, and the 
indicted siRNA were examined by western blotting with anti-p24 capsid, -HSP90, -TSG101, -CHMP2A, -
CHMP2B and –UFD1 antibodies. Viral supernatants were collected and used to infect target HeLa cells. 
Resolved virions present in the 293T supernatant were examined by western blotting with anti-p24 capsid. 
Resolved lysates of infected HeLa cells were examined by western blotting with anti-GFP. Virion release 
was the ratio of released to cellular p24-capsid, as quantified by densitometry (n = 2); infectivity was 
quantified as GFP-signal in target cells, as quantified by densitometry (n = 2).  D, siRNA-transfected HeLa 
cells were fixed and stained with anti-Tubulin. Multinucleate cells (n = 5, ± S.D.) or cells connected by 
midbodies (n = 5, ± S.D.) were scored visually, 300 cells scored per experiment.  
 
Extended Data Figure 7: ESCRT-depletion impairs NE-rim formation. 
A,B. Timelapse microscopy analysis and quantification of NE-rim formation in HeLa cells stably expressing 
YFP-LAP2β and mCh-H2B and treated with the indicated siRNA Scale bar is 10 µm. Time for rim 
formation post anaphase onset given (mins) (Ctrl 8.53 ± 0.09, 226 cells analysed over 8 independent 
experiments; CHMP2A-1, 7.60 ± 0.09, 205 cells analysed over 7 independent experiments; CHMP2A-2, 
6.86 ± 0.12, 37 cells analysed over 2 independent experiments; CHMP2B, 6.92 ± 0.09, 79 cells analysed 
over 4 independent experiments; CHMP2A and CHMP2B, 6.84 ± 0.13, 50 cells analysed over 2 independent 
experiments; CHMP4B, 7.07 ± 0.14, 44 cells analysed over 2 independent experiments; UFD1 9.2 ± 0.18, 39 
cells analysed over 3 independent experiments. All times mean ± S.E.M, in minutes, images representative 
of the indicated number of cell analysed). C. Resolved cell lysates from A were analysed by western-blotting 
with the indicated antisera.  
 
Extended Data Figure 8: ESCRT-depletion does not impair nuclear pore formation. 
A. Schematic of nuclear envelope integrity assay. B. Control siRNA treated HeLa cells reporting nucleo-
cytoplasmic partitioning using the GFP-NLS-βGal assay, average NE compartmentalisation from 20 cells 
presented. Nucleo-cytoplasmic partitioning stabilises at 85 minutes (indicated by arrow). C. 
Immunofluorescence analysis of HeLa cells stably expressing YFP-LAP2β, transfected with the indicated 
siRNA then stained with anti-mAb414 and DAPI (n = 3), Scale bar is 10 µm. D. Mask employed to quantify 
nuclear pore formation by image-based flowcytometry (Imagestream). E.  Imagestream analysis of HeLa 
cells transfected with the indicated siRNA, then stained with anti-mAb414 and DAPI. Nuclear pore intensity 
quantified by mask described in D. Representative images from 2 independent experiments, histogram and 
population averages displayed, graphical quantification of NPC intensity from the indicated number of gated 
cells (Control, 3045; CHMP2A-1, 1256; CHMP2A-2, 2152; CHMP2B, 5237; UFD1-1, 4146; UFD1-3, 
4325; error bars are ± S.D.). 
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Extended Data Figure 9: Requirements for nucleocytoplasmic compartmentalization.  
A. Quantification of NE-sealing from siRNA treated cells as in Figure 4B, (Ctrl 140 cells from 7 
independent experiments; UFD1-1, 60 cells from 3 independent experiments, P = 0.044; UFD1-3, 60 cells 
from 3 independent experiments, P = 0.021; CHMP2B 40 cells from 2 independent experiments, N.S. All 
times quoted ± S.E.M. in minutes; 2-tailed student’s T-test was used to assess significance at the 85-minute 
timepoint). B. Resolved cell lysates from A were analysed by western-blotting with the indicated antisera. C. 
Nuclear envelope integrity assay as performed with cells stably expressing mCh-H2B and GFP-NLS and 
transfected with the indicated siRNA. Differences in nucleo-cytoplasmic partitioning was assessed after 
plateau at the 65 minute timepoint using a 2-tailed Student’s T-test : (Ctrl, 79 cells from 4 independent 
experiments, CHMP2A-1, 60 cells from 3 independent experiments, P = 0.048; CHMP2A-2, 52 cells from 3 
independent experiments, P = 0.011; CHMP3, 28 cells from 3 independent experiments, P = 0.028, error 
bars represent S.E.M.). D, E. HeLa cells stably expressing mCh-H2B and GFP-NLS were transfected with 
the indicated siRNA and imaged live. 60 minutes post anaphase onset, cytoplasmic signal was photo-ablated 
(T = 0) and Recovery of cytoplasmic signal from the nuclear pool was calculated for the indicated conditions 
(Cytoplasmic : Nuclear ratio of GFP-NLS was normalized to T = 0. Ctrl, 21 cells from 4 independent 
experiments; CHMP2A-1, 24 cells from 4 independent experiments, P = 0.04; CHMP2A-2, 23 cells from 4 
independent experiments, P = 0.05; CHMP3, 15 cells from 3 independent experiments, P = 0.004, 2-tailed 
Student’s t-test was used to assess significance after 10 minutes. In D, error bars represent S.E.M. in E, scale 
bar is 10 µm. F. Scoring of multinucleate and midbody-connected HeLa cells transfected with the indicated 
siRNA and stained with anti-tubulin and DAPI (300 cells analysed per condition, n = 4 ± S.D.).  
 
Extended Data Figure 10. Affect of CHMP2A depletion on NE discontinuities.  
A. Presentation of reconstructed tomograms from Figure 4D. B. CHMP2A-depelted cells exhibited more 
non-NPC discontinuities per unit area whilst the number of NPC per unit area was constant, tomograms as 
described in Figure 4E were scored for discontinuities. The internal diameter of NPCs was slightly reduced 
in CHMP2A-depleted cells (Control 84 ± 7.6 nm, CHMP2A-1, 74 ± 8.8 nm; CHMP2A-2, 74 ± 5.7 nm). C. 
Schematic depicting topological equivalent of ESCRT-III-dependent membrane fusion events. 
 
Supplementary Video 1 : CHMP2A forms a reticular network around telophase nuclei 
Deconvolved 3D reconstruction of HeLa cells stained with anti-CHMP2A and DAPI and analysed by 
widefield microscopy, from Extended Data Figure 1C. 
 
Supplementary Video 2 : GFP-CHMP4B transiently localises to telophase nuclei 
Movie of GFP-CHMP4B localisation during the anaphase to telophase transition, from Extended Data 
Figure 1D.  
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Supplementary Video 3 : CHMP2A decorates nucleo-cytoplasmic channels 
3D reconstruction of HeLa cells stained with anti-CHMP2A and DAPI and analysed by correlative light and 
electron tomography, From Figure 1D. 
 
Supplementary Video 4 : Tomographic reconstruction of nascent nuclear envelope 
3D reconstruction of HeLa cells stained with anti-CHMP2A and DAPI and analysed by correlative light and 
electron tomography, as depicted in Figure 1D and Extended Data Figure 2. 
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